Orthofix stock.

Orthofix Medical Inc. completed the transactions contemplated by the definitive Agreement and Plan of Merger, dated as of October 10, 2022 (the “ Merger Agreement”), by and among Orthofix, Orca Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Orthofix (“ Merger Sub”) and SeaSpine Holdings Corporation, a Delaware corporation (“ SeaSpine”).About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation.Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine …

View the latest Orthofix Medical Inc. (OFIX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Orthofix Medical Stock Performance OFIX stock opened at $11.12 on Monday. The company has a quick ratio of 1.13, a current ratio of 2.58 and a debt-to-equity ratio of 0.14.Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ...

LEWISVILLE, Texas, November 08, 2023--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per ...Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including Breg, Inc., and via partnerships with other leading orthopedic product companies, such as Medtronic Sofamor Danek and Kendall Healthcare.Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. ... Stock Orthofix Medical Inc. - Nasdaq . News Orthofix Medical Inc. Transcript : Orthofix Medical Inc., Q2 2023 Earnings Call, Aug 08, 2023. CATEGORIES. …LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)-- Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they have entered into a definitive agreement ...Orthofix Medical Inc. completed the transactions contemplated by the definitive Agreement and Plan of Merger, dated as of October 10, 2022 (the “ Merger Agreement”), by and among Orthofix, Orca Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Orthofix (“ Merger Sub”) and SeaSpine Holdings …

Shares of Orthofix Medical (NASDAQ: OFIX) were down more than 26% as of 2:15 p.m. ET on Tuesday after the healthcare company announced it had fired CEO Keith Valentine, CFO John Bostjancic, and ...

Nov 29, 2023 · Orthofix Reports Third Quarter 2023 Results. LEWISVILLE, Texas-- (BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per share... 13 days ago - Business Wire.

Stock analysis for Orthofix Medical Inc (OFIX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The healthcare stock is down more than 33% so far this year. ... up 61.3% year over year. Even without additional SeaSpine-related sales, Orthofix sales would have been up 7% year over year. The ...About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Real time Orthofix Medical (OFIX) stock price quote, stock graph, news & analysis.Orthofix Medical Inc. (NASDAQ: OFIX) shares fell 5.4% to $10.52 in pre-market trading. Sealed Air will replace Orthofix Medical in the S&P SmallCap 600, …

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today. Of votes cast, 99% of SeaSpine common shares were voted in …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Exhibit 10.5 . ORTHOFIX INTERNATIONAL N.V. AMENDED AND RESTATED . STOCK PURCHASE PLAN, AS AMENDED (showing changes through Amendment No. 4) The Orthofix Inc. Employee Stock Purchase Plan is hereby amended, restated and renamed the “Orthofix International N.V. Amended and Restated Stock Purchase Plan,” and adopted by the Company, effective as of the Effective Date.Orthofix Medical Inc. Enters into Financing Agreement with Blue Torch Finance LLC. Nov. 08. CI. Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q3 Revenue $184M, vs. Street Est of $185.8M. Nov. 08. MT. Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023. The stock sells at ~1x forward sales and has created marginal value above its net asset value ($1.12 for every $1 invested, to be precise). Investors have priced the company at just 1.12x the ...

StockNews.com cut shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning.. Several other research firms also recently commented on OFIX. Stifel Nicolaus downgraded Orthofix Medical from a buy rating to a hold rating and decreased their …

Nov 17, 2023 · Orthofix Medical stock has received a consensus rating of buy. The average rating score is and is based on 3 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Orthofix ... NEW YORK, NY / ACCESSWIRE / October 22, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …há 8 horas ... Orthofix Medical Inc (OFIX) stock has fallen -43.67% over the last 12 months, and the average rating from Wall Street analysts is a Buy.On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation.Orthofix Medical Inc. (OFIX) is a leading global spine and orthopedics company that provides products and services for musculoskeletal health. The stock price, news, quote and history of OFIX are shown on Yahoo Finance, as well as its performance outlook, earnings date, dividend yield, research reports and more. LEWISVILLE, Texas-- ( BUSINESS WIRE )--Orthofix Medical Inc. (NASDAQ:OFIX) today announced preliminary unaudited third quarter 2022 net sales of approximately $114 million, an increase of 1% on a ...Jan 9, 2023 · SeaSpine shares ceased trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern time on January 4, 2023, and holders of SeaSpine common stock are receiving 0.4163 shares of Orthofix common ...

August 08, 2023 at 06:19 pm EDT. LEWISVILLE, Texas (AP) — LEWISVILLE, Texas (AP) — Orthofix Medical Inc. (OFIX) on Tuesday reported a loss of $39.4 million in its second quarter. On a per-share basis, the Lewisville, Texas -based company said it had a loss of $1.07. Earnings, adjusted for non-recurring costs and costs related to mergers and ...

(RTTNews) - Orthofix (OFIX) and SeaSpine (SPNE) have entered into a definitive agreement to combine in an all-stock merger of equals. SeaSpine shareholders will receive 0.4163 shares of Orthofix ...

NEW YORK, Nov. 25, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California ...Dec 1, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Orthofix Medical stock is Hold based on the current 3 hold ratings for OFIX. The average twelve-month price prediction for Orthofix Medical is $14.00 with a high price target of $16.00 and a low price target of $12.00. Learn more on OFIX's analyst rating ... Find the latest Orthofix Medical Inc. (OM2.F) stock quote, history, news and other vital information to help you with your stock trading and investing.SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common ...Nov 29, 2023 · Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983 ... Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix BoaLos Angeles, California--(Newsfile Corp. - September 12, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ: OFIX) for violations of the securities laws. The investigation focuses on …Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.há 5 dias ... ... Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or ...Orthofix Medical has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.

View ORTHOFIX MEDICAL INC OFIX investment & stock information. Get the latest ORTHOFIX MEDICAL INC OFIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023. LEWISVILLE, Texas, October 18, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023 after market close.Orthopedic Procedures. Designed to address the most challenging orthopedic conditions of patients of all ages, our well-rounded product lines and digital services offer solutions for limb reconstruction, whether post-traumatic, correction of deformity, limb lengthening, or pediatric surgery and foot & ankle specialties. Ultimately, we help our ...“Orthofix is a leader in both the demineralized bone matrices (DBM) and cellular allograft markets, and the launch of OsteoCove significantly strengthens our biologics portfolio and builds on our mission to deliver best-in-class products in every major bone grafting category,” said Tyler Lipschultz, President, Orthofix Global Biologics.Instagram:https://instagram. is spacex a public companyinstant virtual bank accountliberty silver dollar coinretired military dental plan Reported on 11/8/23. Get the latest Orthofix Medical Inc (OFIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ... senior living investmentscybertruck pricing Mar 7, 2023 · Orthofix Medical Inc. (NASDAQ:NASDAQ:OFIX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ETCompany ParticipantsAlexa Huerta - Senior Director,... Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per share (“EPS”) was $ (0.77), and adjusted EPS was $0.07. “Orthofix has performed well and operated smoothly following the announcement of our management transition. pgim high yield r6 Sep 12, 2023 · Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Boa Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in 68 countries worldwide. The Company is headquartered in Lewisville, Texas, and has ...